Efficacy and safety of roxadustat for treating anaemia in patients with chronic kidney disease and heart failure: a retrospective cohort study
Roxadustat was effective in correcting and maintaining Hb levels in patients with anaemia, HF and CKD. It did not increase thrombotic and other adverse events, mortality or rehospitalization risks, making it a promising treatment option for anaemia in this population.
Authors
- Jingyi Ren (ORCID: https://orcid.org/0000-0002-9424-4713)
- Lina Su (ORCID: https://orcid.org/0000-0003-1190-7938)
- Lina Feng (ORCID: https://orcid.org/0000-0002-0074-3408)
- Mengxi Yang (ORCID: https://orcid.org/0000-0002-4426-3633)
- Meng Zhen (ORCID: https://orcid.org/0000-0003-2064-1801)
- Zhaoqi Zheng (ORCID: https://orcid.org/0000-0002-5391-4266)
- Jiang Liu (ORCID: https://orcid.org/0000-0002-2836-7651)
- Yan Liang (ORCID: https://orcid.org/0000-0003-4596-587X)
- Li Zhuo
- Bowei Liu (ORCID: https://orcid.org/0009-0008-7603-8474)
Institutions
- Peking University (CN)
- China-Japan Friendship Hospital (CN)
- Chinese General Hospital College of Nursing and Liberal Arts (PH)
- People's Liberation Army No. 150 Hospital (CN)
Publication Details
- Journal
- Clinical Kidney Journal
- Published
- 2025-02-24
- DOI
- https://doi.org/10.1093/ckj/sfaf061
- Citations
- 5
- Primary Topic
- Heart Failure Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 6.94